Egyptian International Pharmaceutical Industries Co. (PHAR)
EGXEgyptian International Pharmaceutical Industries Co.
What Changed
Full IR Briefing →Company Overview
Leadership team data not yet available for this company.
We're expanding our GCC coverage — check back soon.
Recent Announcements
No announcements yet.
Data Sources
See Data Freshness Monitor for platform-wide data quality.
Price Chart
Key Metrics
Governance Score
Insufficient data
0/12 dimensions populated
SouqData provides data for informational purposes only. This does not constitute financial advice, a personal recommendation, or an offer to buy or sell any security. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.
Frequently Asked Questions about Egyptian International Pharmaceutical Industries Co.
Where is Egyptian International Pharmaceutical Industries Co. listed?
Egyptian International Pharmaceutical Industries Co. is listed on the Egyptian Exchange (EGX) in Egypt under the ticker PHAR. SouqData profiles its financials, board and shareholders from public exchange disclosures.
What sector is Egyptian International Pharmaceutical Industries Co. in?
Egyptian International Pharmaceutical Industries Co. (EGX: PHAR) is classified in the Health Technology sector. This classification is what SouqData uses for its sector rankings and peer comparisons.
What is the market cap of Egyptian International Pharmaceutical Industries Co.?
Egyptian International Pharmaceutical Industries Co. (EGX: PHAR) has a market capitalisation of about $264M (USD), according to the latest market data held by SouqData. The figure moves daily with the share price.
Egyptian International Pharmaceutical Industries Co. vs sector peers
Health Technology · small-cap · 5 peers shown| Company | Market cap (USD) | Dividend yield | Governance | Shariah |
|---|---|---|---|---|
| Egyptian International Pharmaceutical Industries Co. (PHAR) | $264M | — | — | — |
| Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA · EGX) | $161M | 1.97% | — | Non-compliant |
| Minapharm Pharmaceuticals (MIPH · EGX) | $106M | 0.53% | — | Non-compliant |
| El-Nile Co. for Pharmaceuticals & Chemical Industries (NIPH · EGX) | $96M | 2.07% | — | Non-compliant |
| Kahira Pharmaceuticals & Chemical Industries Co. (CPCI · EGX) | $81M | 6.08% | — | — |
| Alexandria Company for Pharmaceuticals and Chemical Industries (AXPH · EGX) | $80M | 7.76% | — | — |
Auto-generated peer set — same GICS sector, comparable market-cap band. Governance score is the unified 8-factor model (independence, board size, CEO/chair separation, attendance, auditor, credentials, committees, pay transparency). Shariah uses AAOIFI Standard No. 21. View all 10 sector peers.
Unlock the full SouqData platform
Get unlimited access to 180+ insight pages, AI copilot, deep research reports, watchlists, portfolio tracking, and the full 210-column screener across 11 MENA exchanges.